Streetbeat News

Price Targets

RHP

Wells Fargo analyst Dori Kesten has maintained an Overweight rating on Ryman Hospitality Properties (NYSE:RHP) and increased the price target from $104 to $105.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 3:01 pm

BLDP

Over the last quarter, Ballard Power Systems (NASDAQ:BLDP) received 3 indifferent and 1 somewhat bearish analyst ratings. The average 12-month price target among 4 analysts is $3.94, which is a 26.77% decrease from the previous target of $5.38. The high target is $4.25 and the low target is $3.50.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:00 pm

CZR

Over the past 3 months, 10 Wall Street analysts have provided ratings for Caesars Entertainment (NASDAQ:CZR), with an average 12-month price target of $63.5, a decrease from the previous target of $67.56. The ratings include 3 bullish, 3 somewhat bullish, and 4 indifferent, with no bearish ratings. The high price target is $80.00 and the low is $48.00.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:00 pm

WAT

Waters Corporation (NYSE:WAT) has received 6 analyst ratings in the last quarter, with 5 being indifferent and 1 somewhat bearish. No bullish ratings were given. The average 12-month price target for Waters is $265.83, with a high of $290.00 and a low of $230.00, representing a 7.05% decrease from the previous target of $286.00.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:00 pm

AKYA

Akoya Biosciences (NASDAQ:AKYA) has received analyst ratings within the last quarter, with 1 bullish, 3 somewhat bullish, and no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target among 4 analysts is $8.75, with a high of $11.00 and a low of $7.00. This target has decreased by 36.36% from the previous target of $13.75. Analysts typically review stocks quarterly or after major company updates, considering financial performance and company risks.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:00 pm

ELDN

Eledon Pharma (NASDAQ:ELDN) received 4 analyst ratings in the last quarter, with 2 bullish and 2 somewhat bullish, and no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for ELDN is $11.25, with a high of $13.00 and a low of $9.00. This target is a 55.0% decrease from the previous target of $25.00. Analysts typically review stocks quarterly or after major company updates, considering financial performance and company risks.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:00 pm

DRH

Diamondrock Hospitality (NYSE:DRH) has received 4 analyst ratings in the last quarter, with an average 12-month price target of $9.25, a decrease of 3.85% from the previous target of $9.62. The ratings consist of 1 somewhat bullish and 3 indifferent, with no bullish or bearish ratings. Analysts provide these ratings based on financial statements, meetings, and insider information to guide investors, though they reflect opinions and can be subject to human error.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 3:00 pm

PEB

Wells Fargo analyst Dori Kesten has maintained an Equal-Weight rating on Pebblebrook Hotel Trust (PEB) but has reduced the price target from $16 to $13.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 3:00 pm

IFF

UBS analyst Joshua Spector has downgraded Intl Flavors & Fragrances (IFF) from Buy to Neutral and reduced the price target from $88 to $78.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 2:59 pm

DRH

Wells Fargo analyst Dori Kesten has maintained an Overweight rating on Diamondrock Hospitality (NYSE:DRH) but lowered the price target from $10 to $9.5.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 2:59 pm